Liraglutide (GLP-1) Loss Weight Peptide CAS 204656-20-2
- Ashtarak
- 25/11/2024 11:52
Office
-
Company name
Liraglutide (GLP-1) Loss Weight Peptide CAS 204656-20-2
-
Workspace
Healthcare, Pharmacy
-
Schedule
Full time
-
Education
-
Experience
Liraglutide
CAT Number: A000009
CAS Number: 204656-20-2
Molecular Formula: C172H265N43O51
Molecular Weight: 3751.25
Purity: ≥95%
Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist used primarily in the treatment of type 2 diabetes and obesity. By mimicking the action of endogenous GLP-1, liraglutide enhances insulin secretion in response to meals, reduces glucagon levels, and slows gastric emptying, leading to better blood glucose control. It also promotes weight loss by reducing appetite and increasing satiety. Liraglutide has shown additional cardiovascular benefits in patients with diabetes, making it a critical tool in managing both metabolic and cardiovascular risks. It is administered via subcutaneous injection and is well-tolerated in most patients. -
Sex
-
Age
-
Description
-
Liraglutide
CAT Number: A000009
CAS Number: 204656-20-2
Molecular Formula: C172H265N43O51
Molecular Weight: 3751.25
Purity: ≥95%
Liraglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist used primarily in the treatment of type 2 diabetes and obesity. By mimicking the action of endogenous GLP-1, liraglutide enhances insulin secretion in response to meals, reduces glucagon levels, and slows gastric emptying, leading to better blood glucose control. It also promotes weight loss by reducing appetite and increasing satiety. Liraglutide has shown additional cardiovascular benefits in patients with diabetes, making it a critical tool in managing both metabolic and cardiovascular risks. It is administered via subcutaneous injection and is well-tolerated in most patients.
